The Journal of Rheumatology · 2018 · 15 citations · 14 references
MedicineClinical SciencesInternal MedicineImmunopathologyInflammationPulmonologyInterstitial Lung DiseasePulmonary InflammationSystemic SclerosisConnective Tissue Disease-associated Interstitial Lung DiseaseDisease DurationDisease SubsetsFecal BiomarkersInterstitial Lung Disease DetectionInterstitital Lung DiseaseLung Disease Progression
OBJECTIVE: To evaluate the relationship between fecal calprotectin (FC) and interstitial lung disease (ILD) in systemic sclerosis (SSc). METHODS: The study enrolled 129 outpatients with SSc. Data about disease characteristics, in particular lung involvement, were collected and FC was measured. RESULTS: Patients with ILD (35, 27.1%) had higher values of FC (p < 0.001). In multivariate analysis, these variables were associated with increased risk of ILD: diffuse disease subset, higher modified Rodnan skin score, longer disease duration, higher severity scores, steroid treatment, and higher FC levels, while diverticulosis was protective. CONCLUSION: ILD is independently associated with increased FC levels in SSc.
14
F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al. · Arthritis & Rheumatism · 2013 · 3.4K citations · Full text
Ulrich A. Walker, Alan Tyndall, L. Czirják et al. · Annals of the Rheumatic Diseases · 2007 · 922 citations · Full text
Assessment of disease severity and prognosis.
Thomas A. Medsger, Stefano Bombardieri, László Czirják et al. · PubMed · 2003 · 377 citations
Gabriele Valentini · Annals of the Rheumatic Diseases · 2001 · 324 citations · Full text